Further examination revealed a lesion in the intertrochanteric region of the left femur susceptible to impending fracture.
[**1-11**]: CT scan revealed 7-cm left renal mass.
X-ray revealed lytic lesion with biopsy positive for renal cell carcinoma 3.
[**7-15**]: embolization with RFA and cementation of T10; cryoablation of lesion in left iliac crest 6.
[**2200-11-6**] MRI head (at outside facility) with unchanged left pareital bone lesion but development of contiguous dural enhancement enveloping the left frontal convexity.
MRI chest with possible new 1.4 cm right T8 vertebral lesion.
[**2201-3-6**] MRI abdomen/pelvis with new 2.3 cm left adrenal mass, increase in left intertrachanteric femoral lesion, 4.0x2.2x2.3 from 2.8x1.7x1.7 cm, new 11 mm lesion within tip of left iliac crest, stable large lesion to right iliac [**Doctor First Name 362**].
Physical Exam: Admission Physical Exam: VS: 98.6 HR 126 BP 107/43 RR 19 98% 2L Gen: Caucasian female resting in bed, NAD HEENT: EOMI, PERRL, MMM, OP clear Neck: JVD difficult to appreciate given body habitus CV: irregularly irregular, rapid Resp: unlabored respirations, CTA anteriorly GI: soft NTND no HSM, +BS Ext: +pneumoboots in place Neuro: CNII- CNXII intact, strength and sensation intact throughout Psych: A&OX3, appropriate  Discharge Physical Exam: Afebrile HR 70-80s BP 130-150/60-80s RR 16-18 96-98% RA Gen: Obeses female resting in bed, NAD CV: RRR Resp: unlabored, CTA anteriorly GI: obese, soft, NTND Ext: WWP, difficulty in appreciating edema, palpable radial and DP LLE: dressings c/d/i over left thigh, some surrounding ecchymosis, sensation intact, full strength about knee and ankle Psych: AAOx3  Pertinent Results: URINE CULTURE (Final [**2201-11-12**]):    <10,000 organisms/ml.
CBC: [**2201-11-14**] 04:00AM BLOOD WBC-6.2 RBC-2.75* Hgb-9.0* Hct-27.3* MCV-99* MCH-32.6* MCHC-32.9 RDW-14.8 Plt Ct-228  INR: [**2201-11-18**] 06:24AM BLOOD PT-25.1* INR(PT)-2.4* [**2201-11-17**] 06:10AM BLOOD PT-25.0* INR(PT)-2.4* [**2201-11-16**] 07:10AM BLOOD PT-23.4* INR(PT)-2.2* [**2201-11-15**] 06:38AM BLOOD PT-22.3* INR(PT)-2.1* [**2201-11-14**] 04:00AM BLOOD PT-22.1* PTT-41.2* INR(PT)-2.0*  LFT: [**2201-11-17**] 06:10AM BLOOD ALT-17 AST-19 LD(LDH)-196 AlkPhos-116* TotBili-0.4  Brief Hospital Course: The patient is a 66F with a history of metastatic renal cell carcinoma previously on pazopanib, CAD with STEMI and 2 BMS to LAD, HTN, CHF (EF 45-50%), prior atrial fibrillation, CKD, and hypothyroidism who was found to have a lesion in the left proximal femur with impending pathologic fracture and was admitted for prophylactic intramedullary fixation.
She started on Pazopanib in [**2201-4-7**] and this has been complicated labile blood pressures, ranging from 100s to 200 systolic, requiring increasing anti-hypertensive medications.
However, since stopping pazopanib in mid [**Month (only) **] her blood pressures have typically run 120s to 130s systolic.
She was given 100 mg PO Metoprolol around 1 PM, and was noted at one point after an IV Dilt bolus to have her pressures down to the 88s systolic.
Her blood pressures responded to IV fluids.
Medications on Admission: Home Medications: ATORVASTATIN [LIPITOR] - (Prescribed by Other Provider) - 10 mg  Tablet - 1 Tablet(s) by mouth once a day CLONAZEPAM - 0.5 mg Tablet - 0.5 (One half) Tablet(s) by mouth prn anxiety COLCHICINE - (Prescribed by Other Provider) - 0.6 mg Tablet - 1  Tablet(s) by mouth takes 2 at first signs of flare and then one  daily prn until resolution DILTIAZEM HCL - 120 mg Capsule, Ext Release 24 hr - 1 Capsule(s)  by mouth daily Hold drug with HR < 50 FENTANYL - 75 mcg/hour Patch 72 hr - apply 1 patch to skin every  3 days FUROSEMIDE - 20 mg Tablet - 1 Tablet(s) by mouth PRN HYDROMORPHONE - 12 mg Tablet - 1 Tablet(s) by mouth every [**3-12**] hours as needed for pain LEVOTHYROXINE - 50 mcg Tablet - One Tablet(s) by mouth daily Avoid taking Calcium and the magnesium one hour before and after.
LISINOPRIL - (Prescribed by Other Provider) - 20 mg Tablet - 1 Tablet(s) by mouth once daily METOPROLOL TARTRATE - (Dose adjustment - no new Rx) - 50 mg Tablet - 3 Tablet(s) by mouth twice a day OMEPRAZOLE - (Dose adjustment - no new Rx) - 20 mg Capsule, Delayed Release(E.C.)
ZOLEDRONIC ACID [ZOMETA] - (Prescribed by Other Provider: [**First Name4 (NamePattern1) **] [**Last Name (NamePattern1) 4613**], MD; Dose adjustment - no new Rx) - 4 mg/5 mL Solution - 3.3 mg IV every 28 days ZOLPIDEM - (Prescribed by Other Provider; Dose adjustment - no new Rx) - 5 mg Tablet - 1 Tablet(s) by mouth PRN insomnia ASPIRIN - (Prescribed by Other Provider; Dose adjustment - no new Rx) - 81 mg Tablet, Delayed Release (E.C.)
2. warfarin 2.5 mg Tablet Sig: One (1) Tablet PO Once Daily at 4 PM: Please draw INR and adjust dose for INR between [**3-12**].
Physical Therapy: Activity:   Activity:  Activity as tolerated tid  Right lower extremity:  Touchdown weight bearing (healing fracture with previously placed IMN)  Left lower extremity:  Full weight bearing  Right upper extremity:  Full weight bearing  Left upper extremity:  Full weight bearing  Treatments Frequency:   Wound care:  Site: left thigh x 3  Type:  Surgical  Comment: change daily for 5 additional days with dry sterile dressing and Tegaderm   Followup Instructions: Provider: [**Name10 (NameIs) 706**] MRI Phone:[**Telephone/Fax (1) 327**] Date/Time:[**2201-11-30**] 10:35 Provider: [**First Name11 (Name Pattern1) 640**] [**Last Name (NamePattern4) 4861**], MD Phone:[**Telephone/Fax (1) 1844**] Date/Time:[**2201-11-30**] 11:30 Provider: [**First Name11 (Name Pattern1) 4224**] [**Last Name (NamePattern4) 4225**], MD Phone:[**Telephone/Fax (1) 1228**] Date/Time:[**2201-11-30**] 2:00 Provider: [**Last Name (NamePattern4) **].
[**Last Name (STitle) 67223**], XRT, [**Location (un) 50909**] RI - Pending Date/Time (midweek) Provider: [**First Name8 (NamePattern2) **] [**Name11 (NameIs) **],  [**Telephone/Fax (1) 64624**] Pending Date/Time
